CD8+ T-cell responses to adeno-associated virus capsid in humans

Federico Mingozzi(Children's Hospital of Philadelphia), Marcela V. Maus(Children's Hospital of Philadelphia), Daniel J. Hui(Children's Hospital of Philadelphia), Denise E. Sabatino(Children's Hospital of Philadelphia), Samuel L. Murphy(Children's Hospital of Philadelphia), John E.J. Rasko(University of Sydney), Margaret V. Ragni(Hemophilia Center of Western Pennsylvania), Catherine S. Manno(University of Pennsylvania), Jürg M. Sommer(Bayer (Germany)), Haiyan Jiang(Bayer (Germany)), Glenn F. Pierce(Bayer (Germany)), Hildegund C.J. Ertl(The Wistar Institute), Katherine A. High(Children's Hospital of Philadelphia)
Nature Medicine
March 18, 2007
10.1038/nm1549
Cited by 723

Abstract

Related Papers

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
Catherine S. Manno, Glenn F. Pierce, Valder R. Arruda et al.|Nature Medicine|2006|2.1k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Victor Appay, P. Rod Dunbar, Margaret Callan et al.|Nature Medicine|2002|1.6k
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Guangping Gao, Mauricio R. Alvira, Lili Wang et al.|Proceedings of the National Academy of Sciences|2002|1.5k
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
Richard O. Snyder, Carol H. Miao, Leonard Meuse et al.|Nature Medicine|1999|408
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
Jane Mount, Roland W. Herzog, D. Michael Tillson et al.|Blood|2002|334